Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
15 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250415795863/en/Oak-Hill-Bio-Enters-into-Exclusive-License-Agreement-with-Roche-to-Obtain-Global-Rights-for-a-Phase-3-Ready-Potential-Best-in-Class-Treatment-for-Individuals-with-Angelman-Syndrome
07 Oct 2024
// BUSINESSWIRE
17 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/oak-hill-bio-and-chiesi-group-announce-first-patient-enrolled-in-the-resumed-phase-2b-clinical-study-evaluating-ohb-607-for-the-prevention-of-bronchopulmonary-dysplasia-the-most-common-cause-of-chronic-lung-disease-in-premature-i-302148908.html
ABOUT THIS PAGE